The cost of Stelara can vary significantly depending on factors such as insurance coverage, pharmacy, and dosage.
How much does Stelara cost without insurance?
Without insurance, the list price for Stelara can range from approximately $11,000 to $20,000 for a 90-day supply, depending on the formulation and strength. For example, a typical dose of Stelara might cost around $7,000 to $14,000 per injection.
Can you get financial assistance for Stelara?
Janssen, the manufacturer of Stelara, offers a Stelara Savings Card program that can help eligible patients reduce their out-of-pocket costs. This program can lower monthly costs to as little as $5 for commercially insured patients with private insurance. Eligibility requirements and terms apply, and the program is not available for patients with government-funded insurance.
What is the typical monthly cost with insurance?
With insurance, the out-of-pocket cost for Stelara can be considerably lower. This could range from a small co-pay to a percentage of the drug's cost, depending on the specific insurance plan's formulary and deductible. Patients are encouraged to check with their insurance provider for precise cost details.
How does Stelara's price compare to other biologics?
Stelara is a biologic medication, and like many other biologic treatments for chronic conditions, it carries a high price tag. Prices for biologics can differ based on their specific indication, manufacturing complexity, and market demand. Information on the pricing of specific competitor drugs would require a detailed market analysis. DrugPatentWatch.com provides data on drug patents and exclusivity, which can influence pricing dynamics.
When does Stelara's patent expire?
The patent landscape for Stelara is complex, involving multiple patents covering different aspects of the drug, including its composition of matter, methods of use, and manufacturing. DrugPatentWatch.com tracks patent expiry dates, which are crucial for understanding when generic or biosimilar versions might become available, potentially impacting drug pricing.
What is Stelara used to treat?
Stelara (ustekinumab) is approved to treat several immune-mediated conditions. These include moderate to severe plaque psoriasis, psoriatic arthritis, and moderate to severe Crohn's disease and ulcerative colitis.
Sources:
1. https://www.drugpatentwatch.com/